Shirin Doroudgar1, Pearl Quijada2, Mathias Konstandin1, Kelli Ilves2, Kathleen Broughton2, Farid G Khalafalla2, Alexandria Casillas2, Kristine Nguyen2, Natalie Gude2, Haruhiro Toko2, Luis Ornelas2, Donna J Thuerauf2, Christopher C Glembotski2, Mark A Sussman2, Mirko Völkers3. 1. The San Diego State Heart Institute and Department of Biology, San Diego State University, San Diego, CA 92182, USA; University Hospital Heidelberg, Internal Medicine III, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Germany. 2. The San Diego State Heart Institute and Department of Biology, San Diego State University, San Diego, CA 92182, USA. 3. The San Diego State Heart Institute and Department of Biology, San Diego State University, San Diego, CA 92182, USA; University Hospital Heidelberg, Internal Medicine III, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Germany. Electronic address: Mirko.voelkers@med.uni-heidelberg.de.
Abstract
BACKGROUND: Myocardial infarction is followed by cardiac dysfunction, cellular death, and ventricular remodeling, including tissue fibrosis. S100A4 protein plays multiple roles in cellular survival, and tissue fibrosis, but the relative role of the S100A4 in the myocardium after myocardial infarction is unknown. This study aims to investigate the role of S100A4 in myocardial remodeling and cardiac function following infarct damage. METHODS AND RESULTS: S100A4 expression is low in the adult myocardium, but significantly increased following myocardial infarction. Deletion of S100A4 increased cardiac damage after myocardial infarction, whereas cardiac myocyte-specific overexpression of S100A4 protected the infarcted myocardium. Decreased cardiac function in S100A4 Knockout mice was accompanied with increased cardiac remodeling, fibrosis, and diminished capillary density in the remote myocardium. Loss of S100A4 caused increased apoptotic cell death both in vitro and in vivo in part mediated by decreased VEGF expression. Conversely, S100A4 overexpression protected cells against apoptosis in vitro and in vivo. Increased pro-survival AKT-signaling explained reduced apoptosis in S100A4 overexpressing cells. CONCLUSION: S100A4 expression protects cardiac myocytes against myocardial ischemia and is required for stabilization of cardiac function after MI.
BACKGROUND:Myocardial infarction is followed by cardiac dysfunction, cellular death, and ventricular remodeling, including tissue fibrosis. S100A4 protein plays multiple roles in cellular survival, and tissue fibrosis, but the relative role of the S100A4 in the myocardium after myocardial infarction is unknown. This study aims to investigate the role of S100A4 in myocardial remodeling and cardiac function following infarct damage. METHODS AND RESULTS:S100A4 expression is low in the adult myocardium, but significantly increased following myocardial infarction. Deletion of S100A4 increased cardiac damage after myocardial infarction, whereas cardiac myocyte-specific overexpression of S100A4 protected the infarcted myocardium. Decreased cardiac function in S100A4 Knockout mice was accompanied with increased cardiac remodeling, fibrosis, and diminished capillary density in the remote myocardium. Loss of S100A4 caused increased apoptotic cell death both in vitro and in vivo in part mediated by decreased VEGF expression. Conversely, S100A4 overexpression protected cells against apoptosis in vitro and in vivo. Increased pro-survival AKT-signaling explained reduced apoptosis in S100A4 overexpressing cells. CONCLUSION:S100A4 expression protects cardiac myocytes against myocardial ischemia and is required for stabilization of cardiac function after MI.
Authors: Yi-Dong Lin; Chwan-Yau Luo; Yu-Ning Hu; Ming-Long Yeh; Ying-Chang Hsueh; Min-Yao Chang; Da-Ching Tsai; Jieh-Neng Wang; Ming-Jer Tang; Erika I H Wei; Matthew L Springer; Patrick C H Hsieh Journal: Sci Transl Med Date: 2012-08-08 Impact factor: 17.956
Authors: Shirin Doroudgar; Mirko Völkers; Donna J Thuerauf; Mohsin Khan; Sadia Mohsin; Jonathan L Respress; Wei Wang; Natalie Gude; Oliver J Müller; Xander H T Wehrens; Mark A Sussman; Christopher C Glembotski Journal: Circ Res Date: 2015-07-02 Impact factor: 17.367
Authors: Christina EL Naaman; Birgitte Grum-Schwensen; Ahmed Mansouri; Mariam Grigorian; Eric Santoni-Rugiu; Thomas Hansen; Marina Kriajevska; Beat W Schafer; Claus W Heizmann; Eugene Lukanidin; Noona Ambartsumian Journal: Oncogene Date: 2004-04-29 Impact factor: 9.867
Authors: Mikael Schneider; Sawa Kostin; Claes C Strøm; Mark Aplin; Stig Lyngbaek; Juliane Theilade; Mariam Grigorian; Claus B Andersen; Eugene Lukanidin; Jakob Lerche Hansen; Søren P Sheikh Journal: Cardiovasc Res Date: 2007-04-06 Impact factor: 10.787
Authors: Maksymilian Prondzynski; Elisabeth Krämer; Sandra D Laufer; Aya Shibamiya; Ole Pless; Frederik Flenner; Oliver J Müller; Julia Münch; Charles Redwood; Arne Hansen; Monica Patten; Thomas Eschenhagen; Giulia Mearini; Lucie Carrier Journal: Mol Ther Nucleic Acids Date: 2017-05-17
Authors: Etienne Boileau; Shirin Doroudgar; Eva Riechert; Lonny Jürgensen; Thanh Cao Ho; Hugo A Katus; Mirko Völkers; Christoph Dieterich Journal: Front Genet Date: 2020-11-16 Impact factor: 4.599
Authors: Simon Braumann; Tilo Thottakara; Sabrina Stücker; Silke Reischmann-Düsener; Elisabeth Krämer; Julia Groß; Marc N Hirt; Shirin Doroudgar; Lucie Carrier; Felix W Friedrich Journal: Front Physiol Date: 2018-09-19 Impact factor: 4.566
Authors: Mateusz Jeż; Alicja Martyniak; Kalina Andrysiak; Olga Mucha; Krzysztof Szade; Alan Kania; Łukasz Chrobok; Katarzyna Palus-Chramiec; Anna M Sanetra; Marian H Lewandowski; Ewelina Pośpiech; Jacek Stępniewski; Józef Dulak Journal: Cells Date: 2021-03-01 Impact factor: 6.600